33259 Improvements in anxiety and depression among patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Three-year results from 2 phase 3 trials (CIMPASI-1 and CIMPASI-2).

Details

Language :

English

ISSN :

01909622

Volume :

87

Issue :

3

Database :

Supplemental Index

Journal :

Journal of the American Academy of Dermatology

Publication Type :

Academic Journal

Accession number :

159027746

Full Text :

https://doi.org/10.1016/j.jaad.2022.06.731